Rybelsus is currently approved by Health Canada for Type 2 diabetes, but is prescribed off-label for obesity
A spokesperson for Eli Lilly told CBS News that "all doses of Mounjaro and Zepbound" are available and have been "since early August," and that the "FDA continues to note the shortage as 'resolved.'" The company also raised concerns about unauthorized versions being sold
Type of Medical Condition Being Treated Generally, Ozempic is more likely to be covered (or have a larger portion of the medication cost covered) if it is being used to treat type 2 diabetes, especially when other treatment plans have not been effective
Imaging studies revealed diminished activation in brain regions such as the insula, putamen, and orbitofrontal cortex when exposed to high-calorie food cues, suggesting that GLP1-S reshapes both physiological hunger responses and the motivational aspects of eating
Insert the suppository at bedtime and expect some discharge over the course of the night
GLP-1 Resistance All that to say, there are some patients who report GLP-1 Resistance